top of page
Untitled (2370 x 672 px).png

About Us

From Large Molecules to Small Solutions

Final Logo Bifrost Medicines.png

At Bifrost Medicines, we are pioneering the development of patient-centric medicines utilizing breakthrough large to small molecule bioconversion. Our innovative bioconversion approach combines the powerful effects of biologic therapies with the advantages of small molecules—offering treatments that are more affordable, easier to administer, and accessible to patients worldwide.

Our Leadership

At the heart of our mission is a team of visionary leaders dedicated to driving innovation and delivering impactful solutions.

CFO

Jason Anglin

Jason

Strategic Advisor

Michael Schwab

Michael.png
bottom of page